scorecardresearch
Thursday, September 11, 2025
TopicPlasma therapy

Topic: plasma therapy

Plasma therapy ineffective in reducing Covid-19 mortality, ICMR study says

The PLACID study by ICMR, involving 464 participants in 39 hospitals, is the first and the largest randomised control trial on Covid-19 to be completed in the world.

US NIH experts say not enough data to back plasma therapy for Covid

At a White House press briefing, FDA Commissioner Stephen Hahn and President Donald Trump had claimed convalescent plasma therapy could cut deaths from coronavirus by 35%.

Ex-Assam CM Tarun Gogoi, suffering from Covid, given plasma therapy as health deteriorates

The condition of the 85-year-old former CM deteriorated due to a sudden fall in oxygen saturation levels. Gogoi had tested positive for Covid on 25 August.

‘Deep state’ FDA is taking a beating as review of Covid vaccine approaches

At a time when the FDA needs the public’s trust more than ever, the US agency has been dragged into the political fray in a series of compounding incidents.

Gujarat-based firm gets govt nod for phase 2 trial of Covid drug made from plasma

Drug hyperimmune globulin is manufactured by pooling plasma from recovered Covid patients. Unlike plasma transfusions, the benefit of the drug is it doesn't require blood type matching. 

US FDA rows back on plasma therapy, says it doesn’t give dramatic benefit to Covid patients

FDA Commissioner Stephen Hahn had said Sunday that blood plasma from Covid-19 survivors given to new patients could save huge numbers of lives.

Convalescent plasma therapy holds promise, but here’s why scientists are still studying it

US approves emergency use of convalescent plasma to treat Covid-19, but studies conducted so far don't hold enough evidence to prove it works effectively and without risk. 

Trump’s plasma therapy push could delay clearer understanding of its science, some experts say

Researchers fear FDA's emergency waiver will make it harder to get patients into clinical trials & get a definitive picture on whether & how convalescent plasma treats Covid-19.

US FDA expands use of plasma therapy to treat Covid patients

The move will make it easier to receive the treatment, which Trump has promoted even though studies to prove its benefits haven’t been completed.

Delhi man donates plasma 6 times to Covid patients. Here’s what experts have to say

Delhi resident Tabrej Khan donated plasma 6 times between 18 April and 20 June. He is now planning to donate for a seventh time and sent his blood for antibody test to LNJP hospital.

On Camera

Lifting night shift ban increased female employment in India—only among big firms

Discriminatory laws limit firms from hiring willing women, and removing such barriers can help narrow the economic gap between developing and developed countries.

What’s behind bond yields’ logic-defying spike? The market’s concern over the future

While bond yields tend to fall amid low inflation & interest rate cuts, market experts say they’ve been rising due to concerns over tax collections, fiscal deficit & potential impact of US tariffs.

‘Foreign policy rests on hard power’—from 1965 Indo-Pak war to Op Sindoor, key takeaways for India

A panel of experts moderated by ThePrint’s Editor-in-Chief Shekhar Gupta drew connections between insights of 1965 Indo-Pak War and strategic takeaways highlighted by Op Sindoor.

Punjab is fast becoming the new Northeast. And there’s a message in it for Modi

In its toughest time in decades because of floods, Punjab would’ve expected PM Modi to visit. If he has the time for a Bihar tour, why not a short visit to next-door Punjab?